Use access key #2 to skip to page content.
$4.86 -0.03 (-0.61%)
7/3/2008 1:00 PM

Stereotaxis, Inc. (STXS)

CAPS Rating:
**

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

View All Commentary (STXS)

Recs

1

Avatar agoodtoy (< 20) Submitted: 5/17/07 4:18 PM : Outperform Start Price: $11.47 STXS Score: -40.72

Medical Device maker, leader in it's field. Stereotaxis Niobe System is a cardiology instrument control system for the interventional treatment of coronary artery disease and arrhythmias in the United States, Europe. Cath Labs are getting more and more use. Doctors and Patients want more minimally invasive treatments and shorter recovery times. Been struggling for the last 2 years but their backlog and visibilty are increasing.

Report this Post Replies: 0 | Reply

Featured Broker Partners